Loading
Latest filing published 03 Mar 2026 for Lexicon Pharmaceuticals, INC., €45k.
No signal scores available.
All filings by Rachel Yap Martens on record concern Lexicon Pharmaceuticals, Inc. The record holds 2 filings, all for trades on 28 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 3 March 2026 with a share grant (€45k) in Lexicon Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations